What's in Inova Health Care Services's pipeline?

Inova Health Care Services has 11 drugs in our index: 6 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 2 in Phase 1.

Which companies overlap with Inova Health Care Services's portfolio?

Top competitors by shared drug class: The First Affiliated Hospital with Nanjing Medical University, Seoul National University Hospital, Biosensors Europe SA, Chinese Academy of Medical Sciences, Fuwai Hospital, Hospital Universitari Vall d'Hebron Research Institute.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/inova-health-care-services.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Inova Health Care Services — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inova Health Care Services pipeline: 6 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

6 marketed 0 filed 0 Phase 3 3 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Initial Heparin Dose Modification	Initial Heparin Dose Modification	marketed
Namenda	Namenda	marketed		Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase	Neuroscience
influenza trivalent inactive vaccine	influenza trivalent inactive vaccine	marketed
Vorapaxar and Aspirin	Vorapaxar and Aspirin	marketed
Vorapaxar and Clopidogrel	Vorapaxar and Clopidogrel	marketed	Dual antiplatelet agent	PAR-1 (vorapaxar) and P2Y12 receptor (clopidogrel)	Cardiovascular
Vorapaxar, Aspirin, and Clopidogrel	Vorapaxar, Aspirin, and Clopidogrel	marketed	Antiplatelet agent combination	PAR-1 (vorapaxar); Cyclooxygenase (aspirin); P2Y12 receptor (clopidogrel)	Cardiovascular

Therapeutic area mix

Cardiovascular · 2
Neuroscience · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

The First Affiliated Hospital with Nanjing Medical University · 2 shared drug classes
Seoul National University Hospital · 2 shared drug classes
Biosensors Europe SA · 1 shared drug class
Chinese Academy of Medical Sciences, Fuwai Hospital · 1 shared drug class
Hospital Universitari Vall d'Hebron Research Institute · 1 shared drug class
Kyunghee University Medical Center · 1 shared drug class
Peking University Third Hospital · 1 shared drug class
Rigshospitalet, Denmark · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Inova Health Care Services:

Cite this brief

Drug Landscape (2026). Inova Health Care Services — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/inova-health-care-services. Accessed 2026-05-17.